QT-interval dispersion in type 2 diabetic and non-diabetic patients with post-myocardial infarction

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 18, Issue 2, 2008, Pages 121-126

  Sakabe, Koichi ^a   Fukuda, Nobuo ^a   Fukuda, Yamato ^a   Wakayama, Katsunori ^a   Nada, Teru ^a   Morishita, Satofumi ^a   Shinohara, Hisanori ^a   Tamura, Yoshiyuki ^a  

^a NATIONAL HOSPITAL ORGANIZATION   (Japan)

Author keywords

Insulin therapy; Myocardial infarction; QT interval dispersion; Repolarization inhomogeneity; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; INSULIN; SULFONYLUREA DERIVATIVE;

ACTION POTENTIAL; AGED; ARTICLE; CASE CONTROL STUDY; DIET THERAPY; DRUG EFFECT; ELECTROCARDIOGRAPHY; FEMALE; HEART INFARCTION; HEART MUSCLE CONDUCTION SYSTEM; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; TIME;

ACTION POTENTIALS; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; HEART CONDUCTION SYSTEM; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; SULFONYLUREA COMPOUNDS; TIME FACTORS;

EID: 39549093990     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2006.09.002     Document Type: Article

References (26)

1. Cho E., Rimm E.B., Stampfer M.J., Willett W.C., and Hu F.B. The impact of diabetes mellitus and prior myocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol 40 (2002) 954-960
2. Perkiomaki J.S., Koistinen M.J., Yli-Mayry S., and Huikuri H.V. Dispersion of QT interval in patients with and without susceptibility to ventricular tachyarrhythmias after previous myocardial infarction. J Am Coll Cardiol 26 (1995) 174-179
3. Cardoso C.R., Salles G.F., and Deccache W. Prognostic value of QT interval parameters in type 2 diabetes mellitus: results of a long-term follow-up prospective study. J Diabetes Complications 17 (2003) 169-178
4. Barr C.S., Naas A., Freeman M., Lang C.C., and Struthers A.D. QT dispersion and sudden unexpected death in chronic heart failure. Lancet 343 (1994) 742
5. Robillon J.F., Sadoul J.L., Benmerabet S., Joly-Lemoine L., Fredenrich A., and Canivet B. Assessment of cardiac arrhythmic risk in diabetic patients using QT dispersion abnormalities. Diabetes Metab 25 (1999) 419-423
6. Kuzuya T., Nakagawa S., Satoh J., Kanazawa Y., Iwamoto Y., Kobayashi M., et al. Committee of the Japan Diabetes Society on the diagnostic criteria of diabetes mellitus. Report of the Committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 55 (2002) 65-85
7. Figueredo E.J., Ohnishi Y., Yoshida A., and Yokoyama M. Usefulness of beat-to-beat QT dispersion fluctuation for identifying patients with coronary heart disease at risk for ventricular arrhythmias. Am J Cardiol 88 (2001) 1235-1239
8. Bazett H.C. An analysis of the time-relations of electrocardiograms. Heart 7 (1920) 353-370
9. Sakabe K., Ikeda T., Sakata T., Kawase A., Kumagai K., Tezuka N., et al. Comparison of T-wave alternans and QT interval dispersion to predict ventricular tachyarrhythmia in patients with dilated cardiomyopathy and without antiarrhythmic drugs: a prospective study. Jpn Heart J 42 (2001) 451-457
10. Henry W.L., DeMaria A., Gramiak R., King D.L., Kisslo J.A., Popp R.L., et al. Report of the American Society of Echocardiography Committee on nomenclature and standards in two-dimensional echocardiography. Circulation 62 (1980) 212-217
11. Sahn D.J., DeMaria A., Kisslo J., and Weyman A. Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation 58 (1978) 1072-1082
12. de Simone G., Kizer J.R., Chinali M., Roman M.J., Bella J.N., Best L.G., et al. Normalization for body size and population-attributable risk of left ventricular hypertrophy: the Strong Heart Study. Am J Hypertens 18 (2005) 191-196
13. Yuan S., Wohlfart B., Olsson S.B., and Blomstrom-Lundqvist C. The dispersion of repolarization in patients with ventricular tachycardia: a study using simultaneous monophasic action potential recordings from two sites in the right ventricle. Eur Heart J 16 (1995) 68-76
14. Schinkel A.F., Bountioukos M., Poldermans D., Elhendy A., Valkema R., Vourvouri E.C., et al. Relation between QT dispersion and myocardial viability in ischemic cardiomyopathy. Am J Cardiol 92 (2003) 712-715
15. Bountioukos M., Schinkel A.F., Poldermans D., Rizzello V., Vourvouri E.C., Krenning B.J., et al. QT dispersion correlates to myocardial viability assessed by dobutamine stress echocardiography in patients with severely depressed left ventricular function due to coronary artery disease. Eur J Heart Fail 6 (2004) 187-193
16. Takebayashi K., Sugita R., Tayama K., Aso Y., Takemura Y., and Inukai T. The connection between QT dispersion and autonomic neuropathy in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 111 (2003) 351-357
17. Takahashi N., Nakagawa M., Saikawa T., Watanabe M., Ooie T., Yufu K., et al. Regulation of QT indices mediated by autonomic nervous function in patients with type 2 diabetes. Int J Cardiol 96 (2004) 375-379
18. Hashimoto N., Musha H., Ozawa A., Imai Y., Kawasaki K., Miyazu O., et al. Relationship between infarction location and size to QT dispersion in patients with chronic myocardial infarction. Jpn Heart J 43 (2002) 455-461
19. Chapman N., Mayet J., Ozkor M., Lampe F.C., Thom S.A., and Poulter N.R. QT intervals and QT dispersion as measures of left ventricular hypertrophy in an unselected hypertensive population. Am J Hypertens 14 (2001) 455-462
20. Straus S.M., Kors J.A., De Bruin M.L., van der Hooft C.S., Hofman A., Heeringa J., et al. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults. J Am Coll Cardiol 4 (2006) 362-367
21. Benoit S.R., Mendelsohn A.B., Nourjah P., Staffa J.A., and Graham D.J. Risk factors for prolonged QTc among US adults: Third National Health and Nutrition Examination Survey. Eur J Cardiovasc Prev Rehabil 12 (2005) 363-368
22. Abildstrom S.Z., Jensen B.T., Agner E., Torp-Pedersen C., Nyvad O., Wachtell K., et al. BEAT Study Group. Heart rate versus heart rate variability in risk prediction after myocardial infarction. J Cardiovasc Electrophysiol 14 (2003) 174-175
23. Antoniucci D., Valenti R., Migliorini A., Parodi G., Moschi G., Memisha G., et al. Impact of insulin-requiring diabetes mellitus on effectiveness of reperfusion and outcome of patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Am J Cardiol 93 (2004) 1170-1172
24. Tentolouris N., Matsagura M., Psallas M., Chatzizacharias A., Fotia M., Arvanitis M., et al. Relationship between antidiabetic treatment with QT dispersion during acute coronary syndromes in type 2 diabetes: comparison between patients receiving sulfonylureas and insulin. Exp Clin Endocrinol Diabetes 113 (2005) 298-301
25. Ranade V., Molnar J., Khokher T., Agarwal A., Mosnaim A., and Somberg J.C. Effect of angiotensin-converting enzyme therapy on QT interval dispersion. Am J Ther 6 (1999) 257-261
26. Pittenger B., Gill E.A., Holcslaw T.L., and Bristow M.R. Relation of dose of carvedilol to reduction in QT dispersion in patients with mild to moderate heart failure secondary to ischemic or to idiopathic dilated cardiomyopathy. Am J Cardiol 94 (2004) 1459-1462